UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 730

Sortiert nach

Green Brazilian propolis effects on sperm count and epididymis morphology and oxidative stress

Food and chemical toxicology, 2012-11, Vol.50 (11), p.3956-3962

2012

Volltextzugriff (PDF)

Diffuse brain connectivity changes in Charcot–Marie–Tooth type 1a patients: a resting‐state functional magnetic resonance imaging study

European journal of neurology, 2021-01, Vol.28 (1), p.305-313

2021

Volltextzugriff (PDF)

An Exploratory Comparison Of US And EU Approaches To Oncology Management. Are US Payers Ready For Management Tools Incorporating HTA Methodologies?

Value in health, 2017-10, Vol.20 (9), p.A465

2017

Volltextzugriff (PDF)

Leydig cell number and sperm production decrease induced by chronic ametryn exposure: a negative impact on animal reproductive health

Environmental science and pollution research international, 2015-06, Vol.22 (11), p.8526-8535

2015

Volltextzugriff (PDF)

Early cytotoxic and genotoxic effects of atrazine on Wistar rat liver: A morphological, immunohistochemical, biochemical, and molecular study

Ecotoxicology and environmental safety, 2012-04, Vol.78, p.170-177

2012

Volltextzugriff (PDF)

Meiosis aspects and nucleolar activity in Triatoma vitticeps (Triatominae, Heteroptera)

Genetica, 2006-01, Vol.126 (1-2), p.141-151

2006

Volltextzugriff (PDF)

Paroles en images

Carlos Fausto, Carlo Severi (dir.)

2016

Volltextzugriff (PDF)

Global longitudinal strain and quantitative sensory testing in pre-symptomatic patients with mutation for transthyretin amyloidosis

European heart journal, 2022-10, Vol.43 (Supplement_2)

2022

Volltextzugriff (PDF)

PRS13 Discriminating the Price of a Product Based on the Target Patient Segment by Launching Different Delivery Mechanisms: A Comparison of China, India and Korea

Value in health, 2012-11, Vol.15 (7), p.A642-A642

2012

Volltextzugriff (PDF)

Genotoxic effect and rat hepatocyte death occurred after oxidative stress induction and antioxidant gene downregulation caused by long term fluoride exposure

Chemico-biological interactions, 2017-02, Vol.264, p.25-33

2017

Volltextzugriff (PDF)

HPR167 A Comparison of ICER Health-Benefit Price Benchmarks in the United States to Drug Prices in the United Kingdom and France

Value in health, 2022-12, Vol.25 (12), p.S263-S263

2022

Volltextzugriff (PDF)

Payer and Physicians Evidence and Discount Expectations for Biosimilars in Six Latin American Countries

Value in health, 2013-11, Vol.16 (7), p.A667-A667

2013

Volltextzugriff (PDF)

Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and Mexico

Value in health, 2013-11, Vol.16 (7), p.A687-A687

2013

Volltextzugriff (PDF)

Stakeholder Evidence Requirements and Price Expectations for Biosimilars in Three Asian Markets

Value in health, 2014-11, Vol.17 (7), p.A775-A776

2014

Volltextzugriff (PDF)

Reaching the Middle of the Pyramid: Implications for the P&MA of Pharmaceutical Drugs with the Expanding Middle Class in Brasil, Chile and Colombia

Value in health, 2013-11, Vol.16 (7), p.A674-A674

2013

Volltextzugriff (PDF)

Analysis of the Pricing and Market Access Landscape of Orphan Drugs in Latin America

Value in health, 2013-11, Vol.16 (7), p.A673-A673

2013

Volltextzugriff (PDF)

PCN295 - An Exploratory Comparison Of US And EU Approaches To Oncology Management. Are US Payers Ready For Management Tools Incorporating HTA Methodologies?

Value in health, 2017-10, Vol.20 (9), p.A465-A465

2017

Volltextzugriff (PDF)

PCN343 INVESTIGATING EUROPEAN HTA AND PRICING FOR HISTOLOGY-AGNOSTIC TREATMENTS

Value in health, 2019-11, Vol.22, p.S503

2019

Volltextzugriff (PDF)

PRO35 ANALYZING THE LEVEL OF EVIDENCE REQUIRED FOR ONCOLOGY VERSUS NON-ONCOLOGY ORPHAN DRUGS AS IT RELATES TO PRICE

Value in health, 2019-11, Vol.22, p.S847-S847

2019

Volltextzugriff (PDF)

Toxicological evaluation of ametryn effects in Wistar rats

Experimental and toxicologic pathology : official journal of the Gesellschaft für Toxikologische Pathologie, 2015-10, Vol.67 (10), p.525-532

2015

Volltextzugriff (PDF)

PDG60 The IMPACT of International Reference Pricing (IRP) in France, Italy, Spain, United Kingdom, and Canada to New and Existing Marketed Medications

Value in health, 2020-12, Vol.23, p.S528-S529

2020

Volltextzugriff (PDF)

Synthesis of 2-methyl-5-amino-4-oxo-3-sulfonyl esters as precursors of pseudodipeptides

Letters in Peptide Science, 2002-01, Vol.9 (1), p.11-14

2002

Volltextzugriff (PDF)

PSY163 - IDENTIFICATION OF KEY ORPHAN DRUG ATTRIBUTES IN PREDICTING THE EXPECTED LEVEL OF PAYER MANAGEMENT IN THE US AND EU3

Value in health, 2018-10, Vol.21, p.S464-S464

2018

Volltextzugriff (PDF)

HC3 - Payer and Physicians Evidence and Discount Expectations for Biosimilars in Six Latin American Countries

Value in health, 2013-11, Vol.16 (7), p.A667-A667

2013

Volltextzugriff (PDF)

PCN26 - Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and Mexico

Value in health, 2013-11, Vol.16 (7), p.A687-A687

2013

Volltextzugriff (PDF)

1 – 25 von 730

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(601)
Mit Volltextzugriff
(647)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Green Brazilian propolis effects on sperm count and epididymis morphology and oxidative stress

Diffuse brain connectivity changes in Charcot–Marie–Tooth type 1a patients: a resting‐state functional magnetic resonance imaging study

An Exploratory Comparison Of US And EU Approaches To Oncology Management. Are US Payers Ready For Management Tools Incorporating HTA Methodologies?

Leydig cell number and sperm production decrease induced by chronic ametryn exposure: a negative impact on animal reproductive health

Early cytotoxic and genotoxic effects of atrazine on Wistar rat liver: A morphological, immunohistochemical, biochemical, and molecular study

Meiosis aspects and nucleolar activity in Triatoma vitticeps (Triatominae, Heteroptera)

Paroles en images

Global longitudinal strain and quantitative sensory testing in pre-symptomatic patients with mutation for transthyretin amyloidosis

PRS13 Discriminating the Price of a Product Based on the Target Patient Segment by Launching Different Delivery Mechanisms: A Comparison of China, India and Korea

Genotoxic effect and rat hepatocyte death occurred after oxidative stress induction and antioxidant gene downregulation caused by long term fluoride exposure

HPR167 A Comparison of ICER Health-Benefit Price Benchmarks in the United States to Drug Prices in the United Kingdom and France

Payer and Physicians Evidence and Discount Expectations for Biosimilars in Six Latin American Countries

Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and Mexico

Stakeholder Evidence Requirements and Price Expectations for Biosimilars in Three Asian Markets

Reaching the Middle of the Pyramid: Implications for the P&MA of Pharmaceutical Drugs with the Expanding Middle Class in Brasil, Chile and Colombia

Analysis of the Pricing and Market Access Landscape of Orphan Drugs in Latin America

PCN295 - An Exploratory Comparison Of US And EU Approaches To Oncology Management. Are US Payers Ready For Management Tools Incorporating HTA Methodologies?

PCN343 INVESTIGATING EUROPEAN HTA AND PRICING FOR HISTOLOGY-AGNOSTIC TREATMENTS

PRO35 ANALYZING THE LEVEL OF EVIDENCE REQUIRED FOR ONCOLOGY VERSUS NON-ONCOLOGY ORPHAN DRUGS AS IT RELATES TO PRICE

Toxicological evaluation of ametryn effects in Wistar rats

PDG60 The IMPACT of International Reference Pricing (IRP) in France, Italy, Spain, United Kingdom, and Canada to New and Existing Marketed Medications

Synthesis of 2-methyl-5-amino-4-oxo-3-sulfonyl esters as precursors of pseudodipeptides

PSY163 - IDENTIFICATION OF KEY ORPHAN DRUG ATTRIBUTES IN PREDICTING THE EXPECTED LEVEL OF PAYER MANAGEMENT IN THE US AND EU3

HC3 - Payer and Physicians Evidence and Discount Expectations for Biosimilars in Six Latin American Countries

PCN26 - Impact of Public Payer Concentration on Public Sector Discounts for Selected Cancer Supportive Care Products in Brazil and Mexico

Suchergebnisse filtern